Dechert Advises Medbio on Acquisition of Polymer Conversions

September 10, 2020

Dechert advised Medbio Intermediate Holding LLC in its acquisition of Polymer Conversions, Inc., a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. 

Medbio, a portfolio company of Graham Partners, is a contract manufacturer specializing in clean room injection molding and assembly for the medical and biotechnology industries. 

The Dechert team that advised Medbio includes corporate partner John LaRocca and associates Stephanie Haas and Erin O’Gurek; finance partner Sarah Gelb and associates Zachary Goldberg, Matthew Celentano and Christopher Rodrigues; real estate special counsel Francois Quintard-Morenas; employee benefits partner David Jones and associate Andrew Braid; intellectual property partner Joshua Rawson and associate Noah Shier; labor counsel Ian Downes; environmental partner Abbi Cohen; and tax partner Josh Milgrim and associate Damien Rose.

About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.